Braxia Scientific CEO to Speak at American Psychiatric Association Annual Meeting on Treatment Resistant Depression and Ketamine Guidelines Published in American Journal of Psychiatry - PR Newswire
Submitted by Anonymous (not verified) on Wed, 05/18/2022 - 11:50
